Another member of this family is the well-studied SGLT2, a glucose transporter largely expressed in the kidney and which is a target of gliofozins, drugs used for lowering serum glucose levels in individuals with type 2 diabetes.62 This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.